SCHEMBL5775096

SCHEMBL5775096

COC1CCCN1OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8821786 1.00
Hydrochloric Acid SCHEMBL27624460 0.98
SCHEMBL3612747 0.93 ALDH1A1 (0.32)
SCHEMBL29191460 0.84
SCHEMBL4774239 0.72
SCHEMBL3569489 0.72
SCHEMBL1644988 0.72
SCHEMBL13017409 0.72
SCHEMBL27668050 0.71 SMN1; SMN2 (0.33)
SCHEMBL24715807 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030100457-A1 The use of salts of undecylenoil glutamate and/or undecylenoil hydrolyzate of wheat and/or rice proteins in the formulation of detergent or cosmetic compositions, and compositions containing such salts ZSCHIMMER & SCHWARZ ITALIANA S.P.A. 2003-05-29 US claimed
EP-1221313-A9 Salts of undecylenoyl glutamate or of undecylenoyl hydrolyzate of wheat or rice proteins in detergent or cosmetic compositions Zschimmer &amp; Schwarz Italiana S.p.A. (IT) 2003-01-02 EP claimed
EP-1221313-A2 Salts of undecylenoyl glutamate or of undecylenoyl hydrolyzate of wheat or rice proteins in detergent or cosmetic compositions Zschimmer &amp; Schwarz Italiana S.p.A. (IT) 2002-07-10 EP claimed
US-20240317721-A1 PYRAZOLYL DERIVATIVES AS INHIBITORS OF THE KRAS MUTANT PROTEIN NOVARTIS AG (CH) 2024-09-26 US disclosed
US-20240270740-A1 INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. 2024-08-15 US disclosed
US-20180334435-A1 6-HETEROARYLOXY- OR 6-ARYLOXY-QUINOLINE-2-CARBOXAMIDES AND METHOD OF USE ABBVIE INC. 2018-11-22 US disclosed
US-9969693-B2 6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use ABBVIE INC. (US) 2018-05-15 US disclosed
US-20170226062-A9 6-HETEROARYLOXY- OR 6-ARYLOXY-QUINOLINE-2-CARBOXAMIDES AND METHOD OF USE ABBVIE INC. 2017-08-10 US disclosed
CN-103819459-B Anti-Viral Compounds 艾伯维巴哈马有限公司 2017-05-17 CN disclosed
US-20160355482-A1 6-HETEROARYLOXY- OR 6-ARYLOXY-QUINOLINE-2-CARBOXAMIDES AND METHOD OF USE ABBVIE INC (US) 2016-12-08 US disclosed
US-9452986-B2 6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use ABBVIE INC. (US) 2016-09-27 US disclosed
EP-0873519-A4 HIV PROTEASE INHIBITORS SCRIPPS RESEARCH INST (US) 2005-04-27 EP disclosed
WO-2005021554-A1 THIENOPYRIDINE-PHENYLACET AMIDES AND THEIR DERIVATIVES USEFUL AS NEW ANTI-ANGIOGENIC AGENTS PFIZER INC. (US) 2005-03-10 WO disclosed
US-6833456-B2 Heterocyclic sulfides such as 5-(2-(2R-Hydroxymethyl-pyrrolidine-1-carbonyl)-thieno(3,2-b)pyridin-7 -ylamino)-2-methyl-indole-1-carboxylic acid methylamide, used as angiogenesis inhibitors AGOURON PHARMACEUTICALS, INC. 2004-12-21 US disclosed
EP-1483268-A2 INDOLYL-UREA DERIVATIVES OF THIENOPYRIDINES USEFUL AS ANTI-ANGIOGENIC AGENTS PFIZER INC. (US) 2004-12-08 EP disclosed
US-20040019065-A1 Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use ROMINES WILLIAM HENRY (US) 2004-01-29 US disclosed
WO-2003074529-A2 iNDOLYL-UREA DERIVATIVES OF THIENOPYRIDINES USEFUL AS ANTI-ANGIOGENIC AGENTS PFIZER INC. (US) 2003-09-12 WO disclosed
EP-0873519-A1 HIV PROTEASE INHIBITORS The Scripps Research Institute (US) 1998-10-28 EP disclosed
WO-1997021100-A9 HIV PROTEASE INHIBITORS 1997-10-30 WO disclosed
WO-1997021100-A1 HIV PROTEASE INHIBITORS THE SCRIPPS RESEARCH INSTITUTE (US) 1997-06-12 WO disclosed